
Gpcr
Innovative therapeutics targeting GPCRs to treat complex diseases with precision medicine.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | KRW4.1b Valuation: KRW105.0b | Late VC | |
Total Funding | 000k |
GPCR Therapeutics, Inc. is a biotechnology company specializing in the development of innovative therapeutics targeting G protein-coupled receptors (GPCRs) to treat complex diseases. The company operates in the biopharmaceutical market, focusing on precision medicine to address unmet medical needs. GPCR Therapeutics serves a diverse range of clients, including pharmaceutical companies, healthcare providers, and research institutions. The business model revolves around research and development (R&D) of novel drugs, leveraging proprietary technology to discover and develop new treatments. Revenue is generated through partnerships, licensing agreements, and the commercialization of its therapeutic products. The company is led by a team of experienced professionals with extensive backgrounds in biotechnology, pharmaceuticals, and financial management.
Keywords: GPCRs, therapeutics, precision medicine, biotechnology, biopharmaceutical, drug development, R&D, partnerships, licensing, commercialization.